These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anaesthesia and Parkinson's disease: how to manage with new therapies? Kalenka A; Schwarz A Curr Opin Anaesthesiol; 2009 Jun; 22(3):419-424. PubMed ID: 19342948 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors. Henchcliffe C; Schumacher HC; Burgut FT Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338 [TBL] [Abstract][Full Text] [Related]
9. [The role of selective monoamine oxidase B inhibitors in the therapeutic strategy of Parkinson's disease in the neurology clinics of Tirgu Mures County Emergency Clinical Hospital]. Szász JA; Constantin V; Fazakas PA; Blényesi E; Grieb LG; Balla A; Sárig M; Szegedi K; Bartha EN; Szatmári S Orv Hetil; 2017 Dec; 158(51):2023-2028. PubMed ID: 29250969 [TBL] [Abstract][Full Text] [Related]
10. [Recent progress in treatment of Parkinson's disease]. Narabayashi H Nihon Rinsho; 1990 Dec; 48(12):2943-50. PubMed ID: 2086859 [No Abstract] [Full Text] [Related]
11. Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors. Chen JJ; Fernandez HH Drugs Aging; 2007; 24(8):663-80. PubMed ID: 17702535 [TBL] [Abstract][Full Text] [Related]
12. [Recent progress of therapy in patients with Parkinson's disease]. Yanagisawa N Nihon Naika Gakkai Zasshi; 1993 Jul; 82(7):1109-14. PubMed ID: 8228492 [No Abstract] [Full Text] [Related]
17. [Anaesthesia and Parkinson's disease]. Chhor V; Karachi C; Bonnet AM; Puybasset L; Lescot T Ann Fr Anesth Reanim; 2011; 30(7-8):559-68. PubMed ID: 21530145 [TBL] [Abstract][Full Text] [Related]
18. [Present strategy and future perspective of therapy in Parkinson's disease]. Kuno S No To Shinkei; 1996 Jan; 48(1):18-25. PubMed ID: 8679314 [No Abstract] [Full Text] [Related]
19. Modes of drug delivery used to manage Parkinson's disease. Noble C Nurs Times; 2006 Aug 8-14; 102(32):30-2. PubMed ID: 16922099 [TBL] [Abstract][Full Text] [Related]
20. The therapeutic effect of moclobemide, a reversible selective monoamine oxidase A inhibitor, in Parkinson's disease. Sternic N; Kacar A; Filipovic S; Svetel M; Kostic VS Clin Neuropharmacol; 1998; 21(2):93-6. PubMed ID: 9579294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]